• Binance US Restores US Dollar Transactions After More Than a Year of Discontinuing Support
• Qubetics, Artificial Super Intelligence Alliance, and Stacks: Which is The Best Crypto ICOs to Invest in Now for the Future of Blockchain?
• Kaito AI Is The Latest Project Of The Binance HODLer Airdrop Program
• Hong Kong SFC Unveils Roadmap to Strengthen Virtual Asset Regulation
• Hidden Gem Alert! Pepe Punch Presale Could Be the Next 100x Meme Coin!
• Best Cryptos with 1000X Potential: Qubetics’ Multi-Chain Wallet Reshapes Crypto Security, Polygon’s Layer 2 Innovation, and Celestia’s $3.22 High
• BingX Unveils New Futures Trading Page, Reinforcing Its Position Among Top 5 Derivatives Platforms
• IPO & M&A Blocked, STO Blockchain Could Be a Breakthrough
• Catch the Arctic Pablo Coin’s Wave – 12,618.77% ROI as SPX6900 and Snek Coin Join The Meme Coin Revolution in 2025!
• Why This Presale Is Selling Out Fast! Investors Are Already Seeing 90% Gains
Key Points:
- Vitalik Buterin sold 10 billion MOODENG tokens for 308.7 ETH, donating 260.15 ETH to the Kanro charity for anti-airborne-disease technology.
- Vitalik supports memecoin charity donations, encouraging communities to donate directly or form DAOs to engage in positive-sum contributions.
Vitalik Buterin sold 10 billion MOODENG tokens for 308.7 ETH, donating 260.15 ETH to Kanro charity, emphasizing Vitalik Buterin Charity Donation for disease research.
Vitalik Buterin Charity Donation Supports Disease Research
Vitalik Buterin sold 10 billion MOODENG tokens for 308.7 ETH and then sent 260.15 ETH to the Kanro charity. The donation will fund anti-airborne-disease technologies. He praised memecoins giving something to charities and asked more communities to engage in charity-focused initiatives.
Read more: MegaETH Review: Layer 2 Invested by Vitalik Buterin
Vitalik Buterin’s Commitment to Charity Through Memecoins
As part of his trend of donating proceeds from his sale of MOODENG tokens, Vitalik Buterin fosters memecoin community maximal positivity-sum; this time, the proceeds go to the development of solutions for airborne diseases.
DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing. |